News

PMLive23h

CHMP recommends BeOne Medicines’ Tevimbra for new lung cancer indication

The European Medicines Agency’s human medicines committee has recommended that BeOne Medicines’ Tevimbra (tislelizumab) be ...

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

SIGA Technologies Inc (SIGA) Q2 2025 Earnings Call Highlights: Strong Revenue and Strategic ...

SIGA Technologies Inc (SIGA) reports robust financial performance with $79 million in product revenue and strategic ...

Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 millionAs of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, ...

SIGA advances pediatric and PEP programs as product revenues reach $79M, supported by new BARDA funding

Nguyen also provided updates on the late-stage pipeline, targeting FDA submission for the PEP indication in 2026 and advancing the pediatric program with an IND submission planned for the second half ...

US health agency to wind down mRNA vaccine development

The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...

BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the second quarter of 2025. O ...